A director at Churchill Downs Inc bought 3,800 shares at 130.220USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
>Croissance organique faible au T1 mais au-dessus des attentes - Worldline vient de publier son CA au titre du T1 2024. Il fait ressortir une croissance organique faible à +2.5% mais au-dessus des attentes (ODDO BHF / consensus = +1.2/+0.7%) et en amélioration par rapport au point bas du T4 2023 (+1.3%).Les Services aux Commerçants s’avèrent plus dynamique que prévu (+3.9% dont +6.5% hors arrêt planifié de commerçants – rappel T4 2023 = +3.2%) grâce à de bons rés...
Sidetrade et SHS Viveon AG conviennent d'une offre publique d'achat sur SHS Viveon AG Une offre publique d'achat amicale avec une prime sur les actions de SHS Viveon AGPrix de l’offre d’achat : 3 euros par action SHS Viveon AGDate limite de l'offre d’achat : 17 juin 2024Après la sortie de cote : Pas d’accès au marché pour les actions SHS Viveon AG , plateforme d’intelligence artificielle (IA) dédiée à la sécurisation et à la génération du cashflow des entreprises, annonce aujourd’hui son intention d'acquérir le leader allemand dans les logiciels de gestion des risques de crédit, SHS Viv...
Sidetrade and SHS Viveon AG agree public tender offer for SHS Viveon AG A friendly public tender offer with premium on the SHS Viveon AG sharesTender offer price: €3.00 per SHS Viveon AG share in cashTender offer deadline: June 17, 2024Post-delisting: No open market for SHS Viveon AG shares , the global leader in AI-powered Order-to-Cash applications, today announces its intention to acquire SHS Viveon AG, a German leader in credit risk management software, following an agreement made with its supervisory board. The public tender offer is scheduled for Tuesday May 7, 2024, with plans to...
Finansielle resultater 1. kvartal 2024 Selskabsmeddelelse nr. 31 Nettoresultat på 670 mio. kr. og egenkapitalforrentning på 21,1 % Regnskabet for 1. kvartal 2024 viser et meget tilfredsstillende nettoresultat på 670 mio. kr. og en egenkapitalforrentning på 21,1 %. Bankens basisindtægter realiseres 174 mio. kr. højere end samme periode sidste år, hvilket primært kan henføres til stigning i nettorenteindtægter. Sammenlignet med samme periode sidste år er banken lykkedes med at vokse det samlede forretningsomfang med 3 % (å/å) med en underliggende vækst i udlån på 2 % og i indlån på 4 %. ...
Financial results for Q1 2024 Company announcement no. 31 Net profit of DKK 670 million and return on equity of 21.1% The financial statements for the first quarter of 2024 show a highly satisfactory net profit of DKK 670 million and a return on equity of 21.1%. Core income was DKK 174 million higher than in the same period of last year, driven primarily by an increase in net interest income. Compared with the same period of last year, the Bank grew its total business volume by 3% (y/y) with underlying growth of 2% in lending and 4% in deposits. We are once again pleased to record a...
Huhtamäki Oyj - Managers' Transactions (Beckler) HUHTAMÄKI OYJ MANAGERS' TRANSACTIONS 2.5.2024 AT 09:20 EEST Huhtamäki Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Robert K. BecklerPosition: Member of the Board/Deputy memberIssuer: Huhtamäki OyjLEI: 5493007050SJVMXN6L29Notification type: INITIAL NOTIFICATIONReference number: 60778/13/10 ____________________________________________Transaction date: 2024-04-26Venue: OTCQInstrument type: SHAREISIN: FI0009000459Nature of transaction: ACQUISITION Transactio...
Huhtamäki Oyj - Johdon liiketoimet (Beckler) HUHTAMÄKI OYJ JOHDON LIIKETOIMET 2.5.2024 KLO 09.20 Huhtamäki Oyj - Johdon liiketoimet____________________________________________IlmoitusvelvollinenNimi: Robert K. BecklerAsema: Hallituksen jäsen/varajäsenLiikkeeseenlaskija: Huhtamäki OyjLEI: 5493007050SJVMXN6L29Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 60778/13/10 ____________________________________________Liiketoimen päivämäärä: 2024-04-26Kauppapaikka: OTCQInstrumenttityyppi: OSAKEISIN: FI0009000459Liiketoimen luonne: HANKINTA Liiketoimien yksityiskohtaiset tiedot (1): V...
LHV Pank updated equity research on EfTEN Real Estate Fund AS LHV Pank updated the equity research and price target of EfTEN Real Estate Fund AS (EfTEN; EFT1T) shares. According to the analysis, the price target for the share remained in the range of 19 to 20,1 euros. The mid-point of the target range is 2,6% above the last closing price at Nasdaq Tallinn Stock Exchange. The previous price target for the EfTEN Real Estate Fund AS shares was set in September 2023. LHV forecast on EfTEN Real Estate Fund for this year foresees: (i) EBITDA and dividend will remain at the previous year's...
During the conference call, management tried to maintain a subtle equilibrium between presenting stronger-than-expected Q1 results and tempering somewhat analysts' optimism for FY24, as evidenced by a CSS estimate (EUR1.02bn) already standing well above ADS' revised guidance of "around EUR700m". We
>Upstream : un profil de croissance solide renforcé par les découvertes en Namibie - L’EBITDA T1 2024 ajusté de l’Upstream est ressorti à 591 M€ et 9% au-dessus des attentes. Le groupe guide sur un EBITDA 2024 de la division à 2.1 Md€ qui nous parait assez conservateur et une production >115 kbep/j en ligne avec nos attentes. Cette production devrait croitre de de plus de 30% (+40 kbep/j) avec le démarrage de Bacalhau au Brésil fin 2025 qui devrait atteindre son pl...
>Continued erosion of Cars fundamentals - MBG reported subdued Q1 results Tuesday morning, below expectations (adjusted EBIT 5% below consensus, -10% for the Cars division), see First Take. The group reported a marked erosion of its earnings and margins in the Cars division (adjusted EBIT € 2.3bn, -44% y-o-y, margin 9.0%, -580bp y-o-y), partly offset by a still very solid performance from Vans (adjusted EBIT € 0.8bn, +11% y-o-y, margin 16.3%, -20bp y-o-y). The group ...
>Un CA T1 stable en organique dont +1.7% de mix volume selon nos calculs. - Du contact société post publication du CA T1 (1696 M€, en hausse de 1.6% en publié et stable en organique), nous retenons les éléments suivants : La croissance organique des produits fromagers de 2.5% s’appuie sur un effet mix volume de 1% et une légère hausse des prix de 1.5%. Le groupe bénéficie des relèvements de prix obtenus en 2023 et ceux obtenus cette année sur certains marchés com...
>Q1 beat expectations - GSK reported Q1 sales (+4.4% vs consensus) and core EPS (+15.9% vs consensus) ahead of expectations. Sales were up 10% at cc (+6% GBP). All divisions turned in a good performance: Specialty Medicines (+12.8%, +1% vs css), Vaccines (+11.6%, +5.5% vs consensus) driven by Arexvy (£ 180m - launched in Q3 2023, in line) and Shingrix (+13.4%, +4.4% vs consensus) General Medicine declined less sharply than expected (-4.4%, +7.7% vs consensus). Core EB...
Alkaloid reported another solid set of results in 1Q24, albeit with the yoy comparison on some lines coloured by the reclassification of cost from below to above the operating line. This quarter, the business caught a tailwind from cephalosporin antibiotic sales in Ukraine (the first quarter is typically strong for all antibiotics), but also from recent investments in its Western European markets. Keeping in mind seasonality, the company is well on track to meet its FY24E revenues growth target ...
>2023 another year to forget, but management optimistic about the future - Last year (2023) was again disappointing for Cherry, with it missing initial guidance by a mile on both revenue (€ 126.5m vs c. € 140m guidance, down 4.5% y-o-y) and adjusted EBITDA margin (1.6% vs guidance of c. 10%). The poor 2023 results were due to a mix of internal and external factors. First, management was running a business with a lack of focus (very diversified product portfolio), no d...
>Le CA T1 reflète une croissance plus favorable que prévu à +11% mais les marges restent du même ordre de grandeur que l’an passé sur le trimestre - Le groupe publie en même temps les résultats annuels 2023 complets (les principales données avaient déjà été communiquées le 29 février) et ceux afférents au T1 2024. Le CA 2023 est confirmé à 1969 M€ soit une croissance de 12% et c.8% en organique (CA T4 à 7% soit quasi flat en org avec une Allemagne à -3.5%), l’EBT ...
1Q adj EBITDA decreased by 11% which was close to our and consensus forecasts. Dsm-firmenich expects to see higher vitamin prices as from 2Q and reiterated FY guidance of at least € 1.9bn adjusted EBITDA, with our and consensus forecasts close to € 2bn. The carve out of Animal Nutrition & Health has started and based on a gradual improvement of market conditions as well as earnings support from the € 200m vitamin restructuring program, we believe proceeds of € 3.0-3.5bn for ANH to be possible, w...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.